Droplet Biosciences

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

Fyr Bio

This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.